Skip to content

A clinical trial for the evaluation of the efficacy and safety of kestose on atopic dermatitis in children

A 12 week, multi center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of GF2 on atopic dermatitis in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003876
Enrollment
70
Registered
2019-05-02
Start date
2018-11-07
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : take a one stick of active medication(containing 2mg of GF2 in a 1 stick or Placebo 2 stick though randomaization once daily for 12 weeks.

Sponsors

Samyang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)subject who signs Informed Consent Form with a legal representative who signs the informed consent form before participating in the study 2)subject aged between 1 years and 11 years with atopic dermatitis 3)subject with intermittent or continuous atopic dermatits symptom over 6 months 4)subject with SCORing of Atopic Dermatitis index between 25 and 50 (moderate)

Exclusion criteria

Exclusion criteria: 1)subject with other systemic illnesses or dermatits history except Atopic Dermatitis 2)subject administrating immunosuppressant,antobiotics,corticosteroid, antihistaminic within 4 weeks 3)subject who has taken medicines,chinese medicine, health functional foods within 4 weeks for improvement of atopic dermatiti 4) subject who has treatened phototherapy

Design outcomes

Primary

MeasureTime frame
SCORing of Atopic Dermatitis score (SCORAD)

Secondary

MeasureTime frame
SCORing of Atopic Dermatitis score (SCORAD) subjective score;SCORing of Atopic Dermatitis score (SCORAD) objective score;Investigator’s Global Assessment;Eosinophil count;IFN-?, IL-4, IL-10, IL-13;SCFA(short chain fatty acid) in stools;total IgE

Countries

Korea, Republic of

Contacts

Public ContactBea min

The Catholic University of Korea, St. Vincent's Hospital

jminbae@gmail.com+82-31-881-8982

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026